Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases

US Patent 9180159 · Granted Nov 10, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Microbiota sequence variants of tumor-related antigenic epitopes2025
Antigenic peptides for prevention and treatment of cancer2024
Tools for assessing FimH blockers therapeutic efficiency2024
Microbiota sequence variants of tumor-related antigenic epitopes2023
Keratan sulfate specific transporter molecules2019
C6S specific transporter molecules2018
Efficient transport into white blood cells2018
C4S proteoglycan specific transporter molecules2017
JNK inhibitor molecules2017
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway 2017
Cell-permeable peptide inhibitors of the JNK signal transduction pathway2016
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway 2015